Noemí Reguart (N Reguart, Noemi Reguart)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Future oncology (London, England)

Therapeutic advances in medical oncology

Drugs

Institut d'Investigacions Biomèdiques August Pi i Sunyer

Hospital Clinic, University of Barcelona UB (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institut d'Investigacions Biomèdiques August Pi i Sunyer

Spain

P.I :: Translational Genomics and Targeted Therapeutics

Hospital Clinic, Barcelona

Spain

Consultant :: Medical Oncology

Education History

Hospital Clinic, University of Barcelona UB

Spain

PHD :: Fellowship Medical Oncology

Publications

Jordi Remon, Benjamin Besse, Santiago Ponce Aix, Ana Callejo, Kamal Al-Rabi, Reyes Bernabe, Laurent Greillier, Margarita Majem, Noemí Reguart, Isabelle Monnet, Sophie Cousin, Pilar Garrido Lopez, Gilles Robinet, Rosario Garcia Campelo, Anne Madroszyk, Julien Mazieres, Hubert Curcio, Bartosz Wasag, Yassin Pretzenbacher, Fanny Grillet, Anne-Marie C Dingemans, Rafal Dziadziuszko
Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR -Mutant Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Jordi Remon, Benjamin Besse, Santiago Ponce Aix, Ana Callejo, Kamal Al-Rabi, Reyes Bernabe, Laurent Greillier, Margarita Majem, Noemí Reguart, Isabelle Monnet, Sophie Cousin, Pilar Garrido Lopez, Gilles Robinet, Rosario Garcia Campelo, Anne Madroszyk, Julien Mazieres, Hubert Curcio, Bartosz Wasag, Yassin Pretzenbacher, Fanny Grillet, Anne-Marie C Dingemans, Rafal Dziadziuszko
Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR -Mutant Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jordi Remon, Benjamin Besse, Santiago Ponce Aix, Ana Callejo, Kamal Al-Rabi, Reyes Bernabe, Laurent Greillier, Margarita Majem, Noemí Reguart, Isabelle Monnet, Sophie Cousin, Pilar Garrido Lopez, Gilles Robinet, Rosario Garcia Campelo, Anne Madroszyk, Julien Mazieres, Hubert Curcio, Bartosz Wasag, Yassin Pretzenbacher, Fanny Grillet, Anne-Marie C Dingemans, Rafal Dziadziuszko
Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR -Mutant Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Jordi Remon, Benjamin Besse, Santiago Ponce Aix, Ana Callejo, Kamal Al-Rabi, Reyes Bernabe, Laurent Greillier, Margarita Majem, Noemí Reguart, Isabelle Monnet, Sophie Cousin, Pilar Garrido Lopez, Gilles Robinet, Rosario Garcia Campelo, Anne Madroszyk, Julien Mazieres, Hubert Curcio, Bartosz Wasag, Yassin Pretzenbacher, Fanny Grillet, Anne-Marie C Dingemans, Rafal Dziadziuszko
Overall Survival From the EORTC LCG-163 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR -Mutant Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Luis G Paz-Ares, Stephane Champiat, W Victoria Lai, Hiroki Izumi, Ramaswamy Govindan, Michael J Boyer, Horst-Dieter Hummel, Hossein Borghaei, Melissa Lynne Johnson, Neeltje Steeghs, Fiona Blackhall, Afshin Dowlati, Noemí Reguart, Tatsuya Yoshida, Kai He, Shirish M Gadgeel, Enriqueta Felip Font, Yiran Zhang, Amrita Pati, Mukul Minocha, Sujoy Mukherjee, Amanda Goldrick, Dirk Nagorsen, Nooshin Hashemi Sadraei, Taofeek Kunle Owonikoko
Tarlatamab, a First-In-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small Cell Lung Cancer: An Open-Label, Phase I Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Luis G Paz-Ares, Stephane Champiat, W Victoria Lai, Hiroki Izumi, Ramaswamy Govindan, Michael J Boyer, Horst-Dieter Hummel, Hossein Borghaei, Melissa Lynne Johnson, Neeltje Steeghs, Fiona Blackhall, Afshin Dowlati, Noemí Reguart, Tatsuya Yoshida, Kai He, Shirish M Gadgeel, Enriqueta Felip Font, Yiran Zhang, Amrita Pati, Mukul Minocha, Sujoy Mukherjee, Amanda Goldrick, Dirk Nagorsen, Nooshin Hashemi Sadraei, Taofeek Kunle Owonikoko
Tarlatamab, a first-in-class DLL3-targeted bispecific T cell engager, in recurrent small-cell lung cancer: an open-label, phase 1 study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Jose Manuel González de Aledo-Castillo, Sebastián Casanueva-Eliceiry, Alexandre Soler, D Fuster, V Pastor, Noemí Reguart, Nuria Viñolas, Joan Antón Puig-Butillé, Ivan Vollmer, Pilar Paredes, J A Puig-Butillé
Cell-free DNA concentration and fragment size fraction correlate with FDG PET/CT-derived parameters in NSCLC patients. European journal of nuclear medicine and molecular imaging 48 (11) (2021)
Cristina Teixidó, Noemí Reguart
Using biomarkers to determine optimal combinations with immunotherapy (biomarker discovery perspective). Future oncology (London, England) 16 (23) (2020)
Cristina Aguado, Cristina Teixidó, Ruth Román, Roxana Reyes, Ana Giménez-Capitán, Elba Marin, Carlos Cabrera, Nuria Viñolas, Sergi Castillo, Silvia Muñoz, Ainara Arcocha, Laura López-Vilaró, Ivana Sullivan, Erika Aldeguer, Sonia Rodríguez, Irene Moya, Santiago Viteri, Andrés Felipe Cardona, Ramon Palmero, Cristina Sainz, Miguel Mesa-Guzmán, Maria D Lozano, Andrés Aguilar-Hernández, Alejandro Martínez-Bueno, María González-Cao, Elena Gonzalvo, William P J Leenders, Rafael Rosell, Luis M Montuenga, Aleix Prat, Miguel Ángel Molina-Vila, Noemí Reguart
Multiplex RNA-based detection of clinically relevant MET alterations in advanced non-small cell lung cancer. Molecular oncology 15 (2) (2020)
Noemí Reguart, Elba Marin, Jordi Remon, Roxana Reyes, Cristina Teixido
In Search of the Long-Desired 'Copernican Therapeutic Revolution' in Small-Cell Lung Cancer. Drugs 80 (3) (2020)
Cristina Teixidó, Noelia Vilariño, Roxana Reyes, Noemí Reguart
PD-L1 expression testing in non-small cell lung cancer. Therapeutic advances in medical oncology 10 (2018)

Noemí Reguart.css-eqlu8i{font-size:small;padding-left:4px;} (N Reguart, Noemi Reguart)

Publication Activity (10 Years)

Top Topics

Top Venues

Noemí Reguart (N Reguart, Noemi Reguart)